Viemed Healthcare
VMD
131 hedge funds and large institutions have $166M invested in Viemed Healthcare in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 9 closing their positions.
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
3% more funds holding
Funds holding: 127 → 131 (+4)
9% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 47
1.69% less ownership
Funds ownership: 64.78% → 63.09% (-1.7%)
6% less capital invested
Capital invested by funds: $177M → $166M (-$10.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$4.33M |
| 2 |
FCM
Forager Capital Management
Birmingham,
Alabama
|
+$4.06M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$1.96M |
| 4 |
Two Sigma Investments
New York
|
+$1.12M |
| 5 |
SIM
SummerHaven Investment Management
Stamford,
Connecticut
|
+$825K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$10.7M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$8.38M |
| 3 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
-$3.25M |
| 4 |
PM
Penbrook Management
New York
|
-$774K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$567K |
VMD Hedge Fund Activity: Q3 2025 in Review
131 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2025, worth a combined $166M — down 6.1% from $177M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new VMD positions and 9 closed out — a net gain of 4 holders — while 43 added to existing stakes and 47 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $4.33M. The largest seller was Wasatch Advisors, exiting entirely with an estimated $10.7M sold.
- 131 institutional investors held Viemed Healthcare (VMD) as of Q3 2025, up from 127 in Q2 2025.
- Funds reported $166M of Viemed Healthcare stock for Q3 2025, down 6.1% quarter-over-quarter.
- 13 funds opened new Viemed Healthcare positions in Q3 2025 and 9 closed out, a net change of +4 holders.
- The largest Viemed Healthcare buyer in Q3 2025 was Goldman Sachs, an estimated $4.33M added.
- The largest Viemed Healthcare seller in Q3 2025 was Wasatch Advisors, an estimated $10.7M sold.
Based on aggregated 13F filings for Q3 2025.